U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubChem Compound

Items: 15

1.
Tapinarof cream 1% once daily for the treatment of adults with mild to severe plaque psoriasis: A novel topical therapy targeting the aryl hydrocarbon receptor
April W. Armstrong, Jamie L. McConaha
J Manag Care Spec Pharm. 2023 Dec; 29(12-a Suppl): S1–S13. doi: 10.18553/jmcp.2023.29.12-a.s1
PMCID:
PMC10996039
AbstractArticlePDF–1.3M
2.
First Use of Tapinarof Monotherapy for Seborrhoeic Dermatitis: A Case Report
Naiem T. ISSA, Michael KAISER
Acta Derm Venereol. 2023; 103: 12343. Published online 2023 Jun 27. doi: 10.2340/actadv.v103.12343
PMCID:
PMC10309059
ArticlePDF–818K
3.
AhR agonist tapinarof ameliorates lupus autoimmunity by suppressing Tfh cell differentiation via regulation of the JAK2‐STAT3 signaling pathway
Ying Zhang, Yanyan Pan, Peiyi Zhang, Fang Wang, Ying Han, Kailin Li, Wen Jiang, Jue Wang, Yun Luan, Qian Xin
Immun Inflamm Dis. 2023 Jun; 11(6): e903. Published online 2023 Jun 14. doi: 10.1002/iid3.903
PMCID:
PMC10266146
AbstractArticlePDF–3.1M
4.
A multi-center, double-blind, randomized, placebo- and positive-controlled phase II clinical study of benvitimod for the treatment of atopic dermatitis
Lin Cai, Yan Zhao, Min Zheng, Furen Zhang, Qing Sun, Quanzhong Liu, Jin Hu, Juan Shen, Jianzhong Zhang
Chin Med J (Engl) 2023 Jan 20; 136(2): 251–252. Published online 2023 Feb 15. doi: 10.1097/CM9.0000000000002489
PMCID:
PMC10106160
ArticlePDF–81K
5.
Tapinarof for the treatment of psoriasis
Sofia Nogueira, Maria Alexandra Rodrigues, Ron Vender, Tiago Torres
Dermatol Ther. 2022 Dec; 35(12): e15931. Published online 2022 Oct 21. doi: 10.1111/dth.15931
PMCID:
PMC10078538
AbstractArticlePDF–1.2M
6.
Tapinarof Cream 1%: First Approval
Susan J. Keam
Drugs. 2022; 82(11): 1221–1228. Published online 2022 Aug 8. doi: 10.1007/s40265-022-01748-6
Correction in:
Drugs. 2022; 82(12): 1345.
Correction in:
Drugs. 2022; 82(13): 1433.
PMCID:
PMC9427914
AbstractArticlePDF–869K
7.
Natural Compounds Tapinarof and Galactomyces Ferment Filtrate Downregulate IL-33 Expression via the AHR/IL-37 Axis in Human Keratinocytes
Gaku Tsuji, Akiko Hashimoto-Hachiya, Tomoyo Matsuda-Taniguchi, Ayako Takai-Yumine, Masaki Takemura, Xianghong Yan, Masutaka Furue, Takeshi Nakahara
Front Immunol. 2022; 13: 745997. Published online 2022 May 19. doi: 10.3389/fimmu.2022.745997
PMCID:
PMC9161696
AbstractArticlePDF–2.0M
8.
Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics
John E. Jett, Michael McLaughlin, Mark S. Lee, Lawrence Charles Parish, Janet DuBois, Tooraj Joseph Raoof, Glenn Tabolt, Timothy Wilson, Matthew C. Somerville, Wayne DellaMaestra, Stephen C. Piscitelli
Am J Clin Dermatol. 2022; 23(1): 83–91. Published online 2021 Oct 28. doi: 10.1007/s40257-021-00641-4
PMCID:
PMC8776723
AbstractArticlePDF–673K
9.
IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis
Yen Hai Vu, Akiko Hashimoto-Hachiya, Masaki Takemura, Ayako Yumine, Yasutaka Mitamura, Takeshi Nakahara, Masutaka Furue, Gaku Tsuji
Int J Mol Sci. 2020 Dec; 21(24): 9412. Published online 2020 Dec 10. doi: 10.3390/ijms21249412
PMCID:
PMC7764126
AbstractArticlePDF–2.2M
10.
A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis
Lin Cai, Gen-Hui Chen, Qian-Jin Lu, Min Zheng, Yu-Zhen Li, Jin Chen, Jie Zheng, Fu-Ren Zhang, Jian-Bin Yu, Sen Yang, Fu-Qiu Li, Sheng-Xiang Xiao, Qiu-Ning Sun, Jin-Hua Xu, Xing-Hua Gao, Hong Fang, Tian-Wen Gao, Fei Hao, Quan-Zhong Liu, Ya-Ting Tu, Ruo-Yu Li, Bao-Xi Wang, Dan-Qi Deng, Qing-Shan Zheng, Hong-Xia Liu, Jian-Zhong Zhang
Chin Med J (Engl) 2020 Dec 20; 133(24): 2905–2909. Published online 2020 Nov 9. doi: 10.1097/CM9.0000000000001221
PMCID:
PMC7752683
AbstractArticlePDF–237K
11.
Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis
Masutaka Furue
Int J Mol Sci. 2020 Aug; 21(15): 5382. Published online 2020 Jul 29. doi: 10.3390/ijms21155382
PMCID:
PMC7432778
AbstractArticlePDF–2.5M
12.
Bacterial Autoimmune Drug Metabolism Transforms an Immunomodulator into Structurally and Functionally Divergent Antibiotics
Hyun Bong Park, Tyler N. Goddard, Joonseok Oh, Jaymin Patel, Zheng Wei, Corey E. Perez, Brandon Q. Mercado, Rurun Wang, Thomas P. Wyche, Grazia Piizzi, Richard A. Flavell, Jason M. Crawford
Angew Chem Int Ed Engl. Author manuscript; available in PMC 2021 May 11.
Published in final edited form as: Angew Chem Int Ed Engl. 2020 May 11; 59(20): 7871–7880. Published online 2020 Mar 17. doi: 10.1002/anie.201916204
PMCID:
PMC7200298
AbstractArticlePDF–2.2M
13.
The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology
Simon D. Harding, Elena Faccenda, Christopher Southan, Adam J. Pawson, Pasquale Maffia, Stephen P. H. Alexander, Anthony P. Davenport, Doriano Fabbro, Francesca Levi‐Schaffer, Michael Spedding, Jamie A. Davies
Immunology. 2020 May; 160(1): 10–23. Published online 2020 Mar 2. doi: 10.1111/imm.13175
PMCID:
PMC7160657
AbstractArticlePDF–4.1M
14.
The preparation of 3,5-dihydroxy-4-isopropylstilbene nanoemulsion and in vitro release
Yue Zhang, Jungang Gao, Hetang Zheng, Ran Zhang, Yucui Han
Int J Nanomedicine. 2011; 6: 649–657. Published online 2011 Apr 1. doi: 10.2147/IJN.S17242
PMCID:
PMC3107722
AbstractArticlePDF–1.4M
15.
Identification of two pigments and a hydroxystilbene antibiotic from Photorhabdus luminescens.
J Li, G Chen, H Wu, J M Webster
Appl Environ Microbiol. 1995 Dec; 61(12): 4329–4333. doi: 10.1128/aem.61.12.4329-4333.1995
PMCID:
PMC167744
SummaryPDF–187K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center